formulation development
Novartis' Jennifer Sheng on Solubility Modelling & the Future of Solubilisation
December 10 by Andrea CharlesPoor solubility is an obvious barrier to advancing potentially efficacious drug candidates. In this interview Jennifer Sheng, Fellow at Novartis, discusses the most efficient approaches for...
Optimising the Development of Protein Formulations
July 17 by Pharma IQThe pharmaceutical industry constantly sees the need to develop a marketable and safe protein drugs for mainstream human use as an important issue. However, there are many challenges which...
Predictions for Targeted Drug Delivery with David Elder and Brendan Griffin
December 05 by Andrea CharlesIn this Pharma IQ interview David Elder, Director of Product Development, GlaxoSmithKline and Brendan Griffin Lecturer in Pharmaceutics and Course Director University College Cork, discuss how th...
Ensuring Stability the Biggest Amorphous Challenge for 88.2% of Developers
July 27 by Pharma IQThe use of amorphous pharmaceutical materials is widely considered an effective way of improving favourable drug properties and the latest findings from Pharma IQ suggest that many developers consider...
3 Tips on Overcoming Poor Aqueous Solubility and Stability
February 15 by Helen WinsorWhat are the 7 Deadly Sins of Quality Assurance and Quality Control? Download our free QA QC eBook now to find out! Rene Holm, Head of Preformulation at H L...
Three Top Tips for Optimising Physical Form Selection
February 09 by Andrea CharlesWhat strategies are pharmaceutical companies employing to accelerate early development and preformulation? Michael Mitchell, Head of Pharmaceutical Sciences Oss, Merck, speaks to Andrea Charles from...
Freeze-Drying and Optimising Formulation Development for Biologicals
January 05 by Andrea CharlesDr. Paul Matejschuk, Principal Scientist at the National Institute for Biological Standards and Control, joined Pharma IQ to discuss optimal formulation development, ahead of Lyophilisation for Biolog...
Pharma Bytes: Interview with Per Holm of Lundbeck
January 04 by Andrea CharlesDr. Per Holm, Chief Specialist Product Development and Lifecycle Lundbeck, joined Pharma IQ for a quick Q&A session on formulation development ahead of the Global Preformulation & Fo...
Utilising Solubility Modelling to Reduce the R&D Timeline
December 24 by Pharma IQReducing the time drugs take to get to market is a key focus for a pharmaceutical industry facing the expiry of patents on blockbuster products and the subsequent influx of generics. Poor solubil...
Utilising Accelerated Degradation Studies to Better Predict Product Stability
November 26 by Pharma IQDr. Paul Matejtschuk Principal Scientist at NIBSC, joins Andrea Charles from Pharma IQ, to address the key challenges in optimal formulation development and how advances in freeze drying have imp...
Establishing Predictive Models to Guide and Optimise the Development of Formulas
October 28 by Pharma IQCornelius Pompe, Head of Freeze Dried Product Development at LFB Technologies, speaks to Andrea Charles from Pharma IQ, about the key drivers of the lyophilisation market and shares his insight...
